×

Myelodysplastic Syndrome – Risk Factors & Prevention

Myelodysplastic Syndrome Risk Factors

We do not know the exact cause of MDS. However, some factors have been found to increase its risk. The following are the common myelodysplastic syndrome risk factors:

1. Age

Age is a myelodysplastic syndrome risk factor. Elderly patients are at higher risk for developing MDS. The disease is less common in people below the age of 50 years. Most patients with myelodysplastic syndrome diagnosis are over the age of 60 years.

2. Sex

Gender is also a myelodysplastic syndrome risk factor. Males are relatively at greater risk for developing MDS compared with females. Although the exact reason for this is not known, it has been proposed that the higher risk in men may be due to increased exposure to environmental or occupational pollutants or due to higher smoking habits.

3. Cancer Treatment

Patients with a history of undergoing radiation therapy and chemotherapy are at increased risk for myelodysplastic syndrome. The risk further increases when chemoradiation therapy is administered in the patients. The myelodysplastic syndrome caused by the treatment of cancer is known as treatment-associated MDS.

The risk also depends on the type of drugs used, the dose and frequency of the chemotherapy drugs, and radiation therapy. Patients undergoing stem cell transplantation are also at increased risk for developing MDS because of the involvement of intensive chemotherapy during the procedure.

4. Genetic Syndromes

Certain genetic syndromes increase the risk of myelodysplastic syndrome. These syndromes include Fanconi anemia, Diamond Blackfan anemia, severe congenital neutropenia, Shwachman-Diamond syndrome, familial platelet disorder with a propensity to myeloid malignancy, and congenital dyskeratosis.

Certain blood conditions, such as clonal hematopoiesis of indeterminate significance, idiopathic cytopenia of unknown significance, and clonal cytopenia of unknown significance, also increase the risk of MDS.

5. Smoking

Studies reported an increased risk of myelodysplastic syndrome in people who smoke compared to people who do not smoke or stopped smoking. It may be because of the cancerous substances present in the tobacco. Once these substances are absorbed in the blood, they may travel to the bone marrow and cause abnormalities in the bone marrow cells.

6. Familial MDS

There is also an association between the MDS risk and familial MDS, as the disease runs in certain families because of the inheritance of mutated genes.

7. Environmental Exposure

Environmental and occupational exposure to certain chemicals, including benzene, exhaust gases, ammonia, solvents, pesticides, and metals, are myelodysplastic syndrome risk factors.

Exposure to high-energy radiations, such as those from a nuclear reactor accident, also increases the MDS risk.

Myelodysplastic Syndrome Preventive Measures

Although there is no method for complete myelodysplasia prevention, specific measures lower the risk of MDS. These measures include:


Conclusion

Myelodysplastic syndrome risk factors include old age, male gender, environmental and occupational exposure to certain chemicals, presence of genetic syndrome, family history of MDS, and a history of chemotherapy, radiation therapy, and stem cell transplant. There is no measure for complete myelodysplasia prevention. However, certain measures lower MDS risk. These include avoiding smoking, exposure to toxic chemicals, routine blood tests, preventative health screenings, and genetic counseling.

Frequently Asked Questions

Some patients with a low risk of myelodysplastic syndrome may live for a long duration with appropriate treatment. Supportive therapies also improve quality of life and survival.

Some myelodysplasia prevention measures that help reduce MDS risk include avoiding smoking, routine health screening, avoiding exposure to toxic chemicals, and genetic counseling.

High-risk myelodysplastic syndrome is characterized by a higher percentage of immature blood or bone marrow cells, chromosomal abnormalities, and low levels of healthy blood cells. It has a high risk for progression to acute myeloid leukemia. Patients with high-risk MDS have a low MDS survival rate; patients with high-risk myelodysplastic syndrome have a low MDS survival rate.

Low-risk MDS has a lower percentage of immature cells in the bone marrow, and the patients do not have severe cytopenia. The risk of its progression to acute lymphocytic syndrome is low. The survival rate of myelodysplastic syndrome is high in patients with low-risk MDS.